CAS: 11018-89-6; 3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-Tetrahydroxy-10-(Hydroxymethyl)-13-Methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]Oxy-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1H-Cyclopenta[a]Phenanthren-17-Yl]-2H-Furan-5-One;Octahydrate

该化合物是属于类卡登醇的复杂有机化合物,具有凝固性胶质,具有多氢基质组的类固醇脊椎,具有多种氢氧基,有助于其水利特性;糖味组,特别是6-deoxy-L-mannopyranosyyl组的存在,增强了其在水中的溶解性并影响其生物活动;该化合物的特点是其特定的立体化学特征,以(1,3,5,11)配置为标志,这对它与生物目标的互动至关重要,特别是在心脏液质侧.Card-20(22)-enolide通常以水分形式出现,表明水分子存在于其晶体结构中,这可能影响其稳定性和溶性.该化合物对药理学具有兴趣,因为它具有潜在的治疗作用,特别是在治疗心脏状况方面,因为它可能影响心脏收缩性和节奏.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    📜2-乙酰氨基-3,4,6-三-O-乙酰-2-脱氧-α-D-吡喃葡萄糖酰基氯置于sodium Methylate,三乙胺体系中,用 甲醇,乙腈 用作溶剂,化学反应 16.5H,反应生成毒毛旋花苷g
    参考文献:Glycosides Having Chromophores As Substrates For Sensitive Enzyme Analysis. Iv. Synthesis Of N-Acetyl-.Beta.-D-Glucosaminides Of Fluorescein Derivatives And Their Application To The Rate-Assay Of N-Acetyl-.Beta.-D-Glucosaminidase.
    标题:Glycosides Having Chromophores As Substrates For Sensitive Enzyme Analysis. Iv. Synthesis Of N-Acetyl-.Beta.-D-Glucosaminides Of Fluorescein Derivatives And Their Application To The Rate-Assay Of N-Acetyl-.Beta.-D-Glucosaminidase.
    摘要:通过引入 N-乙酰基-β-D-氨基葡萄糖苷,合成了三种新型 N-乙酰基-β-D-氨基葡萄糖苷,即 2',7'-二氯荧光素单(N-乙酰基-β-D-氨基葡萄糖苷)(6A),荧光素单(N-乙酰基-β-D-氨基葡萄糖苷)(6B)和 2',7'-Dichlorofluorescein Di(N-Acetyl-β-D-Glucosaminide) (7A)是通过在荧光素衍生物中引入 N-Acetyl-β-D-Glucosaminyl 基团,然后去除保护基团而合成的.化合物 6A,6B 和 7A 经 N-乙酰基-β-D-葡糖胺苷酶水解后,在弱酸性速率测定条件(ph 值为 5.0)下,产物在长吸收波长(500,465 和 485 纳米)处显示出较高的吸光度.6A 和 7A 的 Km 值分别为 0.56 和 0.86 Mm.在这些化合物中,7A 被认为是最有可能用于 N-乙酰基-β-D-葡糖胺酶速率测定的发色底物,因为它在酶水解作用下会产生从无色到橙色的明显颜色变化(λmax 280->485 Nm),并且具有超过 30 Mm 的较高水溶性.
    Doi:10.1248/cpb.41.314

    海关参考信息

    专利信息


    专利号:US-6362009-B1
    优先权日:1997-11-21
    标 题 :Solid phase synthesis of heterocycles
    发明人:MUNOZ BENITO; CHEN CHIXU
    权利人:MERCK & CO INC
    摘要:Methods for solid phase and combinatorial synthesis using a resin activation/capture approach are provided. In particular, methods for the production of dihydropyridones, N-acyidihydropyridones, tetrahydropyridones, pyridines, aminopyridines, N-acyltetrahydropyridines and tetrahydropyridines compounds and libraries containing such compounds are provided. Methods for screening the libraries and compounds and pharmaceutical compositions containing compounds prepared by the methods are provided.

    专利号:EP-0658564-B1
    优先权日:1986-04-30
    标题 :Electroluminescent compounds and intermediates in their synthesis
    发明人:MASSEY RICHARD J; POWELL MICHAEL J; MIED PAUL A; POONIAN MOHINDAR S; FENG PETER; CIANA LEOPOLDO DELLA; DRESSICK WALTER J
    权利人:IGEN INT INC
    摘要:Novel compounds for use in electrochemiluminescent assays and characterised by containing the structure        X - Y - ZwhereinX represents one or more nucleotides which may be the same or different, one or more amino acids which may be the same or different, an antibody, an analyte of interest or an analogue of an analyte of interestY represents a linker group attached to X and Z,andZ represents an electrochemiluminescent moiety, and intermediates employed in their synthesis.

    专利号:US-5380847-A
    优先权日:1992-10-22
    标 题 :Synthesis of certain 1-(1-methylpiperidin-4-y1)-3-phenylpyrazolo[4,3-C]pyridines

    专利号:US-2018230127-A1
    优先权日:2015-08-13
    标题 :Bicyclic-Fused Heteroaryl Or Aryl Compounds
    发明人:ANDERSON DAVID RANDOLPH; CURRAN KEVIN JOSEPH; GAVRIN LORI KRIM; GOLDBERG JOEL ADAM; LEE ARTHUR; LOWE MICHAEL DENNIS; PATNY AKSHAY; PIERCE BETSY SUSAN; SAIAH EDDINE; TRZUPEK JOHN DAVID
    权利人:PFIZER
    摘要:Compounds, tautomers and pharmaceutically acceptable salts of the compounds of Formula (Ia) are disclosed which are inhibitors of Interleukin-1 receptor associated kinase (IRAK4). Methods of treatment, methods of synthesis, and intermediates are also disclosed as defined in the specification.

    专利号:RU-2075479-C1
    优先权日:1991-02-04
    标 题 :Arylhydroxyalkylheteroaryl-8-azabicyclo[3,2,1]octanes, method of their synthesis and heteroaryl-8-azabicyclo[3,2,1]octanes

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Younis W, Alamgeer, Schini-Kerth VB, Brentan da Silva D, Junior AG, Bukhari IA, Assiri AM. Role of the NO/cGMP pathway and renin-angiotensin system in the hypotensive and diuretic effects of aqueous soluble fraction from Crataegus songarica K. Koch. J Ethnopharmacol. 2020 Mar 1;249:112400. doi: 10.1016/j.jep.2019.112400. Epub 2019 Nov 16.
    85:73-81. doi: 10.1016/j.vascn.2017.02.001. Epub 2017 Feb 3. 13(6):511-522. doi: 10.1089/zeb.2016.1284. Epub 2016 Aug 25. 79(1):62-70. doi: 10.1016/j.antiviral.2008.01.156. Epub 2008 Feb 21. 27(1):35-9. doi: 10.1016/s0022-0736(05)80108-6. 39(3):161-6. doi: 10.1016/0378-8741(93)90031-y.

    合成参考文献


    摘要:Journal of Pharmacology and Experimental Therapeutics., 197(19), 1976 []
    摘要:Journal of Ethnopharmacology., 39(161), 1993 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知